Exploring the potential of phytochemicals and nanomaterial: A boon to antimicrobial treatment

Kraemer, 2019, Antibiotic pollution in the environment: from microbial ecology to public policy, Microorganisms, 7 Yadav, 2022, Present scenarios and future prospects of herbal nanomedicine for antifungal therapy, J Drug Deliv Sci Technol, 74 Khatoon, 2018, Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention, Heliyon, 4, e01067, 10.1016/j.heliyon.2018.e01067 Nepal, 2018, Self-medication with Antibiotics in WHO Southeast Asian Region: a systematic review, Cureus, 10, e2428 Fair, 2014, Antibiotics and bacterial resistance in the 21st century, Perspect Medicin Chem., 6, 25, 10.4137/PMC.S14459 Hendriksen, 2019, Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage, Nat. Commun., 10, 1124, 10.1038/s41467-019-08853-3 Organization, 2019, New report calls for urgent action to avert antimicrobial resistance crisis, Jt News Release, 29, 2019 Yadav, 2022, Nano-constructs targeting the primary cellular energy source of cancer cells for modulating tumor progression, OpenNano, 8, 10.1016/j.onano.2022.100107 Ganesan, 2008, The impact of natural products upon modern drug discovery, Curr Opin Chem Biol, 12, 306, 10.1016/j.cbpa.2008.03.016 Newman, 2016, Natural products as sources of new drugs from 1981 to 2014, J Nat Prod, 79, 629, 10.1021/acs.jnatprod.5b01055 Cragg, 2013, Natural products: a continuing source of novel drug leads, Biochim Biophys Acta, 1830, 3670, 10.1016/j.bbagen.2013.02.008 Anand, 2019, A comprehensive review on medicinal plants as antimicrobial therapeutics: potential avenues of biocompatible drug discovery, Metabolites, 9, 258, 10.3390/metabo9110258 Tan, 2015, Alexander Fleming (1881–1955): Discoverer of penicillin, Singapore Med J, 56, 366, 10.11622/smedj.2015105 Ventola, 2015, The antibiotic resistance crisis: part 1: causes and threats, P T, 40, 277 Yadav, 2021, Novel archetype in psoriasis management bridging molecular dynamics in exploring novel therapies, Eur J Pharmacol, 907, 10.1016/j.ejphar.2021.174254 Davies, 2010, Origins and evolution of antibiotic resistance, Microbiol Mol Biol Rev, 74, 417, 10.1128/MMBR.00016-10 Patel, 2020, Pathogenesis and molecular targets in treatment of diabetic wounds, Obes Diabetes J Faintuc, Springer Nature Switzerland AG, 747 Nikaido, 2009, Multidrug resistance in bacteria, Annu Rev Biochem, 78, 119, 10.1146/annurev.biochem.78.082907.145923 Preventing Antibiotic Resistance and the Spread of Superbugs | Children’s Hospital of Philadelphia n.d. https://www.chop.edu/news/preventing-antibiotic-resistance-and-spread-superbugs (accessed January 20, 2022). Kadri, 2020, Key takeaways from the U.S. CDC’s antibiotic resistance threats report for frontline providers, Crit Care Med, 48, 939, 10.1097/CCM.0000000000004371 33000 people die every year due to infections with antibiotic-resistant bacteria n.d. https://www.ecdc.europa.eu/en/news-events/33000-people-die-every-year-due-infections-antibiotic-resistant-bacteria (accessed January 20, 2022). Ray S, Das S, Suar M. Molecular Mechanism of Drug Resistance. Drug Resist Bact Fungi, Malaria, Cancer 2017:47–110. https://doi.org/10.1007/978-3-319-48683-3_3. Reygaert, 2018, An overview of the antimicrobial resistance mechanisms of bacteria, AIMS Microbiol, 4, 482, 10.3934/microbiol.2018.3.482 Egorov, 2018, Bacterial enzymes and antibiotic resistance, Acta Nat, 10, 33, 10.32607/20758251-2018-10-4-33-48 Garneau-Tsodikova, 2016, Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives, Medchemcomm, 7, 11, 10.1039/C5MD00344J Bertani, 2018, Function and biogenesis of lipopolysaccharides, EcoSal Plus, 8, 10.1128/ecosalplus.ESP-0001-2018 Choi, 2019, Distinct roles of outer membrane porins in antibiotic resistance and membrane integrity in escherichia coli, Front Microbiol, 10 Valero-Pacheco, 2020, Conservation of the OmpC Porin Among Typhoidal and Non-Typhoidal Salmonella Serovars, Front Immunol, 10, 2966, 10.3389/fimmu.2019.02966 Beceiro, 2013, Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?, Clin Microbiol Rev, 26, 185, 10.1128/CMR.00059-12 Bornet, 2004, Omp35, a new Enterobacter aerogenes porin involved in selective susceptibility to cephalosporins, Antimicrob Agents Chemother, 48, 2153, 10.1128/AAC.48.6.2153-2158.2004 Sharma, 2019, Efflux pump inhibitors for bacterial pathogens: From bench to bedside, Indian J Med Res, 149, 129, 10.4103/ijmr.IJMR_2079_17 Blanco, 2016, Bacterial multidrug efflux pumps: much more than antibiotic resistance determinants, Microorganisms, 4, 14, 10.3390/microorganisms4010014 Sun, 2014, Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations, Biochem Biophys Res Commun, 453, 254, 10.1016/j.bbrc.2014.05.090 Nikaido, 2009, Mechanisms of RND multidrug efflux pumps, Biochim Biophys Acta, 1794, 769, 10.1016/j.bbapap.2008.10.004 Fernández, 2012, Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance, Clin Microbiol Rev, 25, 661, 10.1128/CMR.00043-12 Zgurskaya, 2009, Multicomponent drug efflux complexes: architecture and mechanism of assembly, Future Microbiol, 4, 919, 10.2217/fmb.09.62 Chagas, 2020, An update on staphylococcus aureus NorA Efflux pump inhibitors, Curr Top Med Chem, 20 Grkovic S, Brown M, Skurray R. Regulation of Bacterial Drug Export Systems. Microbiol Mol Biol Rev 2003;66:671–701, table of contents. https://doi.org/10.1128/MMBR.66.4.671-701.2002. Pradel, 2002, The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes, Antimicrob Agents Chemother, 46, 2640, 10.1128/AAC.46.8.2640-2643.2002 Pesingi, 2019, MexAB-OprM efflux pump of pseudomonas aeruginosa offers resistance to carvacrol: a herbal antimicrobial agent, Front Microbiol, 10 Chukwudi, 2016, rRNA binding sites and the molecular mechanism of action of the tetracyclines, Antimicrob Agents Chemother, 60, 4433, 10.1128/AAC.00594-16 Munita, 2016, Mechanisms of antibiotic resistance, Microbiol Spectr, 4, 10.1128/microbiolspec.VMBF-0016-2015 Podlesek, 2020, The DNA damage inducible SOS response is a key player in the generation of bacterial persister cells and population wide tolerance, Front Microbiol, 11, 1785, 10.3389/fmicb.2020.01785 Baharoglu, 2014, SOS, the formidable strategy of bacteria against aggressions, FEMS Microbiol Rev, 38, 1126, 10.1111/1574-6976.12077 Poulin-Laprade, 2015, Transfer activation of SXT/R391 integrative and conjugative elements: unraveling the SetCD regulon, Nucleic Acids Res, 43, 2045, 10.1093/nar/gkv071 Baharoglu, 2010, Conjugative DNA transfer induces the bacterial SOS response and promotes antibiotic resistance development through integron activation, PLoS Genet, 6, e1001165, 10.1371/journal.pgen.1001165 Gill, 2015, Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens, Chem Biol Drug Des, 85, 56, 10.1111/cbdd.12478 Hawkey, 2000, Mechanisms of resistance to antibiotics, Intensive Care Med, 26, S9, 10.1007/s001340051112 Wang, 2011, Insights from modeling the 3D structure of New Delhi metallo-β-lactamse and its binding interactions with antibiotic drugs, PLoS One, 6, e18414, 10.1371/journal.pone.0018414 Yadav K, Pradhan M, Singh D, Singh MR. Targeting autoimmune disorders through metal nanoformulation in overcoming the fences of conventional treatment approaches. In: Rezaei N, editor. Transl. Autoimmun., vol. 2, Academic Press; 2022, p. 361–93. https://doi.org/10.1016/b978-0-12-824390-9.00017-7. Blizzard, 2014, Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin(®), Bioorg Med Chem Lett, 24 Sader, 2022, Antimicrobial activities of ceftazidime-avibactam and comparator agents against gram-negative organisms isolated from patients with urinary tract infections in U.S. Medical Centers, 2012 to 2014, Antimicrob Agents Chemother, 60, 4355, 10.1128/AAC.00405-16 Mondon, 2013, Selective trihydroxyazepane NagZ inhibitors increase sensitivity of Pseudomonas aeruginosa to β-lactams, Chem Commun (Camb), 49 Kongkham, 2020, Opportunities and challenges in managing antibiotic resistance in bacteria using plant secondary metabolites, Fitoterapia, 147, 10.1016/j.fitote.2020.104762 Lomovskaya, 2001, Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy, Antimicrob Agents Chemother, 45, 105, 10.1128/AAC.45.1.105-116.2001 Paulasova, 2004, The peptide nucleic acids (PNAs): a new generation of probes for genetic and cytogenetic analyses, Ann Génétique, 47, 349, 10.1016/j.anngen.2004.07.001 Yadav, 2022, Dermal nanomedicine: Uncovering the ability of nucleic acid to alleviate autoimmune and other related skin disorders, J Drug Deliv Sci Technol, 73 Mj, 1999, Biological properties of structurally related α-Helical cationic antimicrobial peptides, Infect Immun, 67, 2005, 10.1128/IAI.67.4.2005-2009.1999 Rasko, 2010, Anti-virulence strategies to combat bacteria-mediated disease, Nat Rev Drug Discov, 9, 117, 10.1038/nrd3013 O’Loughlin, 2013, A quorum-sensing inhibitor blocks pseudomonas aeruginosa virulence and biofilm formation, Proc Natl Acad Sci U S A, 110 Del Pozo, 2008, Bioelectric effect and bacterial biofilms. A systematic review, Int J Artif Organs, 31, 786, 10.1177/039139880803100906 Cvitkovitch, 2003, Quorum sensing and biofilm formation in Streptococcal infections, J Clin Invest, 112, 1626, 10.1172/JCI200320430 Roy, 2018, Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action, Virulence, 9, 522, 10.1080/21505594.2017.1313372 Schiavo, 2001, The bacterial toxin toolkit, Nat Rev Mol Cell Biol, 2, 530, 10.1038/35080089 Lowy, 2010, Treatment with monoclonal antibodies against clostridium difficile toxins, N Engl J Med, 362, 197, 10.1056/NEJMoa0907635 López, 2010, Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coli, Antimicrob Agents Chemother, 54, 239, 10.1128/AAC.00343-09 Saenz, 2007, Identification and Characterization of small molecules that inhibit intracellular toxin transport, Infect Immun, 75, 4552, 10.1128/IAI.00442-07 Chatterjee, 2013, Structure and Biophysics of Type III Secretion in Bacteria, Biochemistry, 52, 2508, 10.1021/bi400160a Yamazaki, 2012, Derivatives of plant phenolic compound affect the type III secretion system of Pseudomonas aeruginosa via a GacS-GacA two-component signal transduction system, Antimicrob Agents Chemother, 56, 36, 10.1128/AAC.00732-11 Veenendaal, 2009, Small-Molecule Type III Secretion System Inhibitors Block Assembly of the Shigella Type III Secreton, J Bacteriol, 191, 563, 10.1128/JB.01004-08 Tj, 2009, Characterization of the Effects of Salicylidene Acylhydrazide Compounds on Type III Secretion in Escherichia coli O157: H7, Infect Immun, 77, 4209, 10.1128/IAI.00562-09 Yang, 2000, LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells, J Exp Med, 192, 1069, 10.1084/jem.192.7.1069 Cirioni, 2006, LL-37 protects rats against lethal sepsis caused by gram-negative bacteria, Antimicrob Agents Chemother, 50, 1672, 10.1128/AAC.50.5.1672-1679.2006 Singh, 2022, Immune System and Mechanism of Immunomodulation, 1 Yadav, 2022, Macrophage-associated disorders: pathophysiology, treatment challenges, and possible solutions, Macrophage Target Deliv Syst Springer, 10.1007/978-3-030-84164-5_4 Shaykhiev, 2005, Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure, Am J Physiol Cell Mol Physiol, 289, L842, 10.1152/ajplung.00286.2004 Rivas-Santiago, 2013, Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models, PLoS One, 8, e59119, 10.1371/journal.pone.0059119 Li, 2006, Neutral sulfate berberine modulates cytokine secretion and increases survival in endotoxemic mice, Acta Pharmacol Sin, 27, 1199, 10.1111/j.1745-7254.2006.00368.x Lu, 2009, Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy, Proc Natl Acad Sci U S A, 106, 4629, 10.1073/pnas.0800442106 Curtright, 2012, Phage Therapy: Emergent Property Pharmacology, J Bioanal Biomed, S6 Barbieri, 2017, Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity, Microbiol Res, 196, 44, 10.1016/j.micres.2016.12.003 Aneshwari, 2022, Standardization and comparative evaluation of phytochemical content and antioxidant activity of Alocasia indica and Tephrosia purpurea, Int J Health Sci (Qassim), 241 Tirkey, 2021, Potential of neoteric phytoactives and herbs for targeting pathophysiological modules of arthritis, Bull Environ Pharmacol Life Sci, 10, 273 Yadav, 2020, Challenges and need of delivery carriers for bioactives and biological agents: an introduction, Adv Ave Dev Nov Carriers Bioact Biol Agents, Elsevier, 1 Yadav, 2020, Commercial aspects and market potential of novel delivery systems for bioactives and biological agents, Adv Ave Dev Nov Carriers Bioact Biol Agents, Elsevier, 595, 10.1016/B978-0-12-819666-3.00020-1 Khameneh, 2019, Review on plant antimicrobials: a mechanistic viewpoint, Antimicrob Resist Infect Control, 8, 118, 10.1186/s13756-019-0559-6 Yadav, 2019, Promising Phytoactives Candidates for Efficacious Treatment of Psoriasis and Other Skin Disorders, J Ravishankar Univ, 31, 10, 10.52228/JRUB.2018-31-1-2 Sahu, 2021, Antiviral nanomaterials as potential targets for malaria prevention and treatment, Viral Antivir Nanomater, CRC Press, 401, 10.1201/9781003136644-21 Shin, 2018, The multi-faceted potential of plant-derived metabolites as antimicrobial agents against multidrug-resistant pathogens, Microb Pathog, 116, 209, 10.1016/j.micpath.2018.01.043 Tiwari, 2021, Plant synthetic biology for producing potent phyto-antimicrobials to combat antimicrobial resistance, Biotechnol Adv, 48, 10.1016/j.biotechadv.2021.107729 Verma, 2015, Impact of various factors responsible for fluctuation in plant secondary metabolites, J Appl Res Med Aromat Plants, 2, 105 Suarez, 2005, Structure-function characterization and optimization of a plant-derived antibacterial peptide, Antimicrob Agents Chemother, 49, 3847, 10.1128/AAC.49.9.3847-3857.2005 Nohynek, 2006, Berry phenolics: antimicrobial properties and mechanisms of action against severe human pathogens, Nutr Cancer, 54, 18, 10.1207/s15327914nc5401_4 Ultee, 1999, Mechanisms of action of carvacrol on the food-borne pathogen Bacillus cereus, Appl Environ Microbiol, 65, 4606, 10.1128/AEM.65.10.4606-4610.1999 Aghayan, 2017, The Effects of Berberine and Palmatine on Efflux Pumps Inhibition with Different Gene Patterns in Pseudomonas aeruginosa Isolated from Burn Infections, Avicenna J Med Biotechnol, 9, 2 Zhang, 2004, Evaluation of Epigallocatechin Gallate and Related Plant Polyphenols as Inhibitors of the FabG and FabI Reductases of Bacterial Type II Fatty-acid Synthase*, J Biol Chem, 279, 30994, 10.1074/jbc.M403697200 Yu, 2020, The alarming antimicrobial resistance in ESKAPEE pathogens: Can essential oils come to the rescue?, Fitoterapia, 140, 10.1016/j.fitote.2019.104433 Upadhyay, 2014, Phytol derivatives as drug resistance reversal agents, ChemMedChem, 9, 1860, 10.1002/cmdc.201402027 Cottarel, 2007, Combination drugs, an emerging option for antibacterial therapy, Trends Biotechnol, 25, 547, 10.1016/j.tibtech.2007.09.004 Dwivedi, 2014, 4-Hydroxy-α-tetralone and its derivative as drug resistance reversal agents in multi drug resistant Escherichia coli, Chem Biol Drug Des, 83, 482, 10.1111/cbdd.12263 Shriram, 2018, Inhibiting Bacterial Drug Efflux Pumps via Phyto-Therapeutics to Combat Threatening Antimicrobial Resistance, Front Microbiol, 9, 2990, 10.3389/fmicb.2018.02990 Ochensberger, 2015, Plant derived inhibitors of bacterial efflux pumps: an update, Phytochem Rev, 14 Bag, 2014, Efflux-pump inhibitory activity of a gallotannin from Terminalia chebula fruit against multidrug-resistant uropathogenic Escherichia coli, Nat Prod Res, 28, 1280, 10.1080/14786419.2014.895729 Maurya, 2013, Antibacterial and synergy of clavine alkaloid lysergol and its derivatives against nalidixic acid-resistant Escherichia coli, Chem Biol Drug Des, 81, 484, 10.1111/cbdd.12103 Wagner, 2009, Synergy research: approaching a new generation of phytopharmaceuticals, Phytomedicine, 16, 97, 10.1016/j.phymed.2008.12.018 Gorlenko, 2020, Plant Secondary Metabolites in the Battle of Drugs and Drug-Resistant Bacteria: New Heroes or Worse Clones of Antibiotics?, Antibiot (Basel, Switzerland), 9, 170 Pradhan, 2022, COVID-19: clinical presentation and detection methods, J Immunoass Immunochem, 43, 1951291, 10.1080/15321819.2021.1951291 Yadav, 2022, Insight and Perspective on Omicron’s Development, Behaviour, and Vaccine Breakthrough: Next Sequelae of COVID-19, J Young Pharm, 14, 283, 10.5530/jyp.2022.14.56 Fleitas Martínez, 2019, Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition, Front Cell Infect Microbiol, 9 Asfour, 2018, Anti-Quorum Sensing Natural Compounds, J Microsc Ultrastruct, 6, 1, 10.4103/JMAU.JMAU_10_18 Grad, 2007, Isolation and functional analysis of mitochondria from the nematode Caenorhabditis elegans, Methods Mol Biol, 372, 51, 10.1007/978-1-59745-365-3_4 Khare, 2021, Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens, Front Pharmacol, 12 Vinod, 2012, Phytochemical constituents and pharmacological activities of Betula alba Linn.-A Review, Int J PharmTech Res, 4 Wang, 2017, The antimicrobial activity of nanoparticles: present situation and prospects for the future, Int J Nanomedicine, 12, 1227, 10.2147/IJN.S121956 Din, 2017, Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors, Int J Nanomedicine, 12, 7291, 10.2147/IJN.S146315 Singh, 2017, The role of nanotechnology in the treatment of viral infections, Ther Adv Infect Dis, 4, 105 Yadav, 2021, Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies, Prog Biomater, 10, 1, 10.1007/s40204-021-00154-7 Patra, 2018, Nano based drug delivery systems: recent developments and future prospects, J Nanobiotechnology, 16, 71, 10.1186/s12951-018-0392-8 Lee, 2019, Nanoparticles in the treatment of infections caused by multidrug-resistant organisms, Front Pharmacol, 10, 1153, 10.3389/fphar.2019.01153 Yadav, 2021, Nanovesicles delivery approach for targeting steroid mediated mechanism of antipsoriatic therapeutics, J Drug Deliv Sci Technol, 65 Malam, 2009, Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer, Trends Pharmacol Sci, 30, 592, 10.1016/j.tips.2009.08.004 Wang, 2014, Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals, J Nutr Biochem, 25, 363, 10.1016/j.jnutbio.2013.10.002 Yadav, 2020, Multifaceted targeting of cationic liposomes via co-delivery of anti-IL-17 siRNA and corticosteroid for topical treatment of psoriasis, Med Hypotheses, 145, 10.1016/j.mehy.2020.110322 Wagner, 1994, Liposomal doxorubicin in AIDS-related Kaposi’s sarcoma: long-term experiences, Clin Investig, 72, 417, 10.1007/BF00180514 Dymek, 2022, Liposomes as biocompatible and smart delivery systems – the current state, Adv Colloid Interface Sci, 309, 10.1016/j.cis.2022.102757 Guimarães, 2021, Design of liposomes as drug delivery system for therapeutic applications, Int J Pharm, 601, 10.1016/j.ijpharm.2021.120571 Campbell, 1983, Toxicity of some charged lipids used in liposome preparations, Cytobios, 37, 21 Mozafari, 2010, Nanoliposomes: preparation and analysis, Methods Mol Biol, 605, 29, 10.1007/978-1-60327-360-2_2 Felgner, 1994, Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations, J Biol Chem, 269, 2550, 10.1016/S0021-9258(17)41980-6 Atanase, 2021, Micellar drug delivery systems based on natural biopolymers, Polymers (Basel), 13, 477, 10.3390/polym13030477 Khandelia, 2006, Driving engineering of novel antimicrobial peptides from simulations of peptide–micelle interactions, Biochim Biophys Acta - Biomembr, 1758, 1224, 10.1016/j.bbamem.2006.03.010 Lavasanifar, 2002, Block copolymer micelles for the encapsulation and delivery of amphotericin B, Pharm Res, 19, 418, 10.1023/A:1015127225021 Li, 2015, Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals, Chin J Nat Med, 13, 641 Matsumura, 2008, Polymeric micellar delivery systems in oncology, Jpn J Clin Oncol, 38, 793, 10.1093/jjco/hyn116 Aqil, 2013, Bioavailability of phytochemicals and its enhancement by drug delivery systems, Cancer Lett, 334, 133, 10.1016/j.canlet.2013.02.032 Fahimirad S, Hatami M. Nanocarrier-Based Antimicrobial Phytochemicals, 2019. https://doi.org/10.1016/B978-0-12-815322-2.00013-4. Tadros, 2004, Formation and stability of nano-emulsions, Adv Colloid Interface Sci, 108–109, 303, 10.1016/j.cis.2003.10.023 Anton, 2011, Nano-emulsions and micro-emulsions: clarifications of the critical differences, Pharm Res, 28, 978, 10.1007/s11095-010-0309-1 Nabawy, 2022, Dual antimicrobial-loaded biodegradable nanoemulsions for synergistic treatment of wound biofilms, J Control Release, 347, 379, 10.1016/j.jconrel.2022.05.013 Nair, 2010, Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer, Biochem Pharmacol, 80, 1833, 10.1016/j.bcp.2010.07.021 Mehnert, 2001, Solid lipid nanoparticles: production, characterization and applications, Adv Drug Deliv Rev, 47, 165, 10.1016/S0169-409X(01)00105-3 Pradhan, 2021, Statistically optimized calcipotriol fused nanostructured lipid carriers for effectual topical treatment of psoriasis, J Drug Deliv Sci Technol, 61 Agrawal, 2021, Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design, Biomed Pharmacother, 141, 10.1016/j.biopha.2021.111919 Wissing, 2004, Solid lipid nanoparticles for parenteral drug delivery, Adv Drug Deliv Rev, 56, 1257, 10.1016/j.addr.2003.12.002 Yadav, 2021, Development and characterization of corticosteroid loaded lipid carrier system for psoriasis, Res J Pharm Technol, 14, 966, 10.5958/0974-360X.2021.00172.4 Bilia, 2014, Flavonoids loaded in nanocarriers: an opportunity to increase oral bioavailability and bioefficacy, Food Nutr Sci, 05 Calzoni, 2019, Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies, J Funct Biomater, 10, 10.3390/jfb10010004 Das, 2011, Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery, AAPS PharmSciTech, 12, 62, 10.1208/s12249-010-9563-0 Yousefi, 2019, Lipid-based nano delivery of antimicrobials to control food-borne bacteria, Adv Colloid Interface Sci, 270, 263, 10.1016/j.cis.2019.07.005 Sadat Tabatabaei Mirakabad, 2014, PLGA-based nanoparticles as cancer drug delivery systems, Asian Pac J Cancer Prev, 15, 517, 10.7314/APJCP.2014.15.2.517 Makadia, 2011, Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier, Polymers (Basel), 3, 1377, 10.3390/polym3031377 Sen, 2015, Probing the potential of Apigenin liposomes in enhancing bacterial membrane perturbation and integrity loss, J Colloid Interface Sci, 453 Zafar, 2021, Bioactive Apigenin loaded oral nano bilosomes: Formulation optimization to preclinical assessment, Saudi Pharm J, 29, 269, 10.1016/j.jsps.2021.02.003 Zhu, 2014, Enhanced oral bioavailability of capsaicin in mixed polymeric micelles: Preparation, in vitro and in vivo evaluation, J Funct Foods, 8, 358, 10.1016/j.jff.2014.04.001 Chang, 2013, Physicochemical properties and antimicrobial efficacy of carvacrol nanoemulsions formed by spontaneous emulsification, J Agric Food Chem, 61, 10.1021/jf402147p Iannitelli, 2011, Potential antibacterial activity of carvacrol-loaded Poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm, Int J Mol Sci, 12, 5039, 10.3390/ijms12085039 Liolios, 2009, Liposomal incorporation of carvacrol and thymol isolated from the essential oil of Origanum dictamnus L. and in vitro antimicrobial activity, Food Chem, 112, 77, 10.1016/j.foodchem.2008.05.060 Hill, 2013, Antimicrobial efficacy of poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped cinnamon bark extract against Listeria monocytogenes and Salmonella typhimurium, J Food Sci, 78, N626, 10.1111/1750-3841.12069 Lu, 2018, Preparation, characterization, and antimicrobial activity of nanoemulsions incorporating citral essential oil, J Food Drug Anal, 26, 82, 10.1016/j.jfda.2016.12.018 Ding, 2017, Curcumin liposomes interfere with quorum sensing system of Aeromonas sobria and in silico analysis, Sci Rep, 7, 8612, 10.1038/s41598-017-08986-9 Schiborr, 2014, The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes, Mol Nutr Food Res, 58, 516, 10.1002/mnfr.201300724 Muniyappan, 2021, Green synthesis of gold nanoparticles using Curcuma pseudomontana isolated curcumin: Its characterization, antimicrobial, antioxidant and anti- inflammatory activities, Environ Chem Ecotoxicol, 3, 117, 10.1016/j.enceco.2021.01.002 Balasubramanian, 2005, Design of biodegradable nanoparticles: a novel approach to encapsulating poorly soluble phytochemical ellagic acid, Nanotechnology, 16, 2819, 10.1088/0957-4484/16/12/014 de Tavares, 2021, Design and characterization of ellagic acid-loaded zein nanoparticles and their effect on the antioxidant and antibacterial activities, J Mol Liq, 341, 116915, 10.1016/j.molliq.2021.116915 Moghimipour, 2012, Preparation and characterization of liposomes containing essential oil of Eucalyptus camaldulensis leaf, Jundishapur J Nat Pharm Prod, 7, 117, 10.17795/jjnpp-5261 Moghimi, 2016, Superior antibacterial activity of nanoemulsion of Thymus daenensis essential oil against E. coli, Food Chem, 194, 410, 10.1016/j.foodchem.2015.07.139 Fazly Bazzaz, 2018, Solid lipid nanoparticles carrying Eugenia caryophyllata essential oil: the novel nanoparticulate systems with broad-spectrum antimicrobial activity, Lett Appl Microbiol, 66, 506, 10.1111/lam.12886 Pereira, 2015, Nanoencapsulation of hydrophobic phytochemicals using poly (dl-lactide-co-glycolide) (PLGA) for antioxidant and antimicrobial delivery applications: Guabiroba fruit (Campomanesia xanthocarpa O. Berg) study, LWT - Food Sci Technol, 63, 100, 10.1016/j.lwt.2015.03.062 Varona, 2011, Liposomal incorporation of Lavandin essential oil by a thin-film hydration method and by particles from gas-saturated solutions, Ind Eng Chem Res, 50, 2088, 10.1021/ie102016r Holz, 2018, Menthol-loaded PLGA micro and nanospheres: synthesis, characterization and degradation in artificial Saliva, Mater Res, 21, 10.1590/1980-5373-mr-2017-0488 Guerra-Rosas, 2017, Antimicrobial activity of nanoemulsions containing essential oils and high methoxyl pectin during long-term storage, Food Control, 77, 131, 10.1016/j.foodcont.2017.02.008 Gortzi, 2007, Evaluation of the antimicrobial and antioxidant activities of Origanum dictamnus extracts before and after encapsulation in liposomes, Molecules, 12, 932, 10.3390/12050932 Cortesi, 2017, Nanostructured lipid carriers (NLC) for the delivery of natural molecules with antimicrobial activity: production, characterisation and in vitro studies, J Microencapsul, 34, 63, 10.1080/02652048.2017.1284276 Srivastava, 2013, Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage, Int J Nanomedicine, 8, 1451 Milanezi, 2019, Antioxidant, antimicrobial and cytotoxic activities of gold nanoparticles capped with quercetin, Saudi Pharm J SPJ Off Publ Saudi Pharm Soc, 27, 968 Montenegro, 2017, Rosemary essential oil-loaded lipid nanoparticles. In vivo topical activity from gel vehicles, Pharmaceutics, 9, 10.3390/pharmaceutics9040048 Van de Ven, 2011, PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation, Int J Pharm, 420, 122, 10.1016/j.ijpharm.2011.08.016 Deng, 2016, Physical characterization and antioxidant activity of thymol solubilized Tween 80 micelles, Sci Rep, 6, 38160, 10.1038/srep38160 Pivetta, 2018, Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties, Colloids Surfaces B Biointerfaces, 164, 281, 10.1016/j.colsurfb.2018.01.053 Engel, 2017, Antimicrobial activity of free and liposome-encapsulated thymol and carvacrol against Salmonella and Staphylococcus aureus adhered to stainless steel, Int J Food Microbiol, 252, 18, 10.1016/j.ijfoodmicro.2017.04.003 Ganea, 2010, Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles, Nanotechnology, 21, 10.1088/0957-4484/21/28/285104 Ghaderi, 2017, Development of antimicrobial nanoemulsion-based delivery systems against selected pathogenic bacteria using a thymol-rich Thymus daenensis essential oil, J Appl Microbiol, 123, 832, 10.1111/jam.13541 Nasseri, 2016, Antifungal activity of Zataria multiflora essential oil-loaded solid lipid nanoparticles in-vitro condition, Iran J Basic Med Sci, 19, 1231